CD274 and non-small cell lung carcinoma: The pooled results found that NSCLC patients with PD-L1+ CTCs appeared to have a longer PFS than those with negative PD-L1 expression in CTCs, but this difference did not achieve statistical significance (HR = 0.79; 95% CI 0.59–1.06, P = 0.12).